Alpha-GPC: The Choline Form with the Best Cognitive Trial Data
Alpha-glycerophosphocholine (Alpha-GPC, also called choline alphoscerate) is a choline-containing phospholipid found naturally in milk and produced inside the body from phosphatidylcholine. Among choline forms sold as supplements, it has the most clinical data — mostly for cognitive decline in older adults and, in much smaller trials, for explosive athletic performance.
Cognitive Decline Evidence
Alpha-GPC is registered as a prescription drug in several European countries (e.g. Gliatilin, Delecit) for cognitive deficits, mostly in mixed Alzheimer’s / cerebrovascular populations. The ASCOMALVA trial (Amenta 2012; PMID 22959283; DOI 10.1016/j.jns.2012.07.003) randomised Alzheimer’s patients with co-existing ischaemic cerebrovascular injury to donepezil + Alpha-GPC 1,200 mg/day or donepezil + placebo. The 12-month interim analysis (91 of a planned 210 patients) showed less decline on MMSE, ADAS-cog, IADL, and caregiver-distress scales in the combination arm; longer-term follow-up reports from the same group continued to favour the combination. The finding is promising but limited to that specific population — Alpha-GPC is not established as monotherapy for Alzheimer’s disease.
Athletic Applications
The Bellar 2015 RCT in the Journal of the International Society of Sports Nutrition (PMID 26582972; DOI 10.1186/s12970-015-0103-x) gave 13 college-aged men 600 mg/day of Alpha-GPC for 6 days in a placebo-controlled crossover and found a significant increase in isometric mid-thigh pull peak force versus placebo (p=0.044), with a non-significant trend on upper-body isometric force. Smaller acute-dosing studies have reported transient growth-hormone increases. The overall evidence base is much smaller than for creatine or caffeine and not all studies have been positive (e.g. acute-ingestion trials of choline-containing supplement stacks have shown no effect on power or anaerobic capacity).
Choline Status
Alpha-GPC is a bioavailable choline source that crosses the blood–brain barrier. Per gram, it delivers about 40% choline by mass — in the same neighbourhood as choline bitartrate, with mechanistic claims (but not yet hard outcome data) of better CNS delivery than salt forms. For everyday choline intake, eggs, liver, and soybeans deliver more choline per dollar than any supplement.
The TMAO Question
Observational and mechanistic work has linked dietary choline (and gut-microbial conversion to trimethylamine N-oxide, TMAO) to higher cardiovascular event rates in some cohorts. The relationship is not yet causal and has not been replicated in randomised trials of choline supplementation. While that question is unresolved, it makes sense to match supplemental choline intake to actual need rather than mega-dose.
Practical Notes
300–600 mg one to two times daily is typical, with meals to reduce mild GI effects. Avoid in pregnancy due to limited safety data. Anyone with bipolar disorder should know that some choline-related compounds have been associated with mood destabilisation in case reports — evidence is limited but worth flagging if you have a personal or family history.
Sources
- Amenta F, et al. "The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer’s disease with cerebrovascular injury: interim results." Journal of the Neurological Sciences, 2012. PMID 22959283; DOI 10.1016/j.jns.2012.07.003.
- Bellar D, LeBlanc NR, Campbell B. "The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength." Journal of the International Society of Sports Nutrition, 2015. PMID 26582972; DOI 10.1186/s12970-015-0103-x.
- Traini E, Bramanti V, Amenta F. "Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline-containing phospholipid with a still interesting profile as cognition enhancing agent." Current Alzheimer Research, 2013. PMID 24059325; DOI 10.2174/15672050113109990134.